Complying with the Sunshine Act could be costly

04/29/2012 | MedCityNews.com

Drug and device makers could end up paying upwards of $200,000 in the first year the Sunshine Act is in force, driven by filing fees, legal fees and information technology upgrades, lawyer Sheva Sanders said at a LifeScience Alley conference. Eight states have laws regarding disclosure of financial relationships between manufacturers and health care providers, with varying fees and requirements.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ